Planet Labs PBC (NYSE:PL) Trading 16.1% Higher – Here’s What Happened

Planet Labs PBC (NYSE:PLGet Free Report) rose 16.1% during mid-day trading on Thursday . The stock traded as high as $40.23 and last traded at $39.9640. Approximately 19,470,752 shares changed hands during mid-day trading, an increase of 39% from the average daily volume of 14,052,066 shares. The stock had previously closed at $34.41.

Key Stories Impacting Planet Labs PBC

Here are the key news stories impacting Planet Labs PBC this week:

  • Positive Sentiment: Large, concentrated call‑option buying signals bullish investor/speculator interest; recent unusual activity included roughly 28,645 calls traded, well above average, suggesting momentum traders are positioned for more upside. Traders Purchase Large Volume of Planet Labs PBC Call Options (NYSE:PL)
  • Positive Sentiment: Company‑level catalysts reported include new defense contracts and a claimed satellite AI breakthrough — items that can boost revenue visibility and win government/business customers over time. Planet Labs (PL) Stock Gains Ground on Defense Contracts and Satellite AI Breakthrough
  • Positive Sentiment: Sector momentum: a broad space‑sector rally (coverage noting White House space initiatives, SpaceX IPO speculation and NASA’s Artemis II) has lifted space equities, driving short‑term buying interest in PL. Planet Labs Stock Soars Amid Space Sector Surge
  • Positive Sentiment: Analyst/media momentum plays: PL is being recommended in some pre‑SpaceX‑IPO stock lists as a way to play broader space/geo‑intelligence upside. 2 stocks to buy before SpaceX IPO
  • Neutral Sentiment: Valuation check / investor debate: after a ~10x one‑year surge, analysts and columnists are asking whether PL is already priced for perfection — useful reading for investors weighing new entries vs. profit‑taking. Is It Too Late To Consider Planet Labs (PL) After Its 10x One Year Surge?
  • Negative Sentiment: Fundamentals and recent results remain a headwind: PL missed EPS estimates in its March quarter (reported loss larger than expected), has negative margins and high leverage metrics — factors that increase downside risk if sentiment cools.

Wall Street Analysts Forecast Growth

PL has been the subject of several research reports. Wedbush lifted their price target on shares of Planet Labs PBC from $30.00 to $40.00 and gave the company an “outperform” rating in a research report on Friday, March 20th. Weiss Ratings reissued a “sell (d-)” rating on shares of Planet Labs PBC in a research report on Thursday, January 22nd. Needham & Company LLC lifted their price target on shares of Planet Labs PBC to $40.00 and gave the company a “buy” rating in a research report on Friday, March 20th. Cantor Fitzgerald lifted their price target on shares of Planet Labs PBC from $20.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, March 20th. Finally, Northland Securities set a $28.00 price target on Planet Labs PBC in a report on Tuesday, January 13th. Six analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $29.61.

Get Our Latest Stock Report on PL

Planet Labs PBC Price Performance

The company has a current ratio of 1.65, a quick ratio of 1.64 and a debt-to-equity ratio of 2.37. The business has a 50-day moving average price of $28.45 and a 200 day moving average price of $21.19. The stock has a market cap of $13.32 billion, a PE ratio of -49.33 and a beta of 1.83.

Planet Labs PBC (NYSE:PLGet Free Report) last issued its quarterly earnings results on Thursday, March 19th. The company reported ($0.48) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.43). Planet Labs PBC had a negative net margin of 80.22% and a negative return on equity of 69.61%. The firm had revenue of $86.82 million for the quarter, compared to analysts’ expectations of $78.17 million. The firm’s revenue was up 41.1% on a year-over-year basis. As a group, research analysts forecast that Planet Labs PBC will post -0.37 earnings per share for the current fiscal year.

Insider Transactions at Planet Labs PBC

In other news, CFO Ashley F. Johnson sold 200,000 shares of the company’s stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $35.10, for a total transaction of $7,020,000.00. Following the transaction, the chief financial officer owned 1,895,162 shares of the company’s stock, valued at $66,520,186.20. This represents a 9.55% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Vijaya Gadde sold 20,000 shares of the company’s stock in a transaction on Thursday, January 22nd. The shares were sold at an average price of $26.77, for a total value of $535,400.00. Following the transaction, the director directly owned 250,169 shares in the company, valued at $6,697,024.13. This represents a 7.40% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 492,249 shares of company stock worth $15,500,339 over the last quarter. 17.53% of the stock is currently owned by corporate insiders.

Institutional Trading of Planet Labs PBC

A number of institutional investors have recently added to or reduced their stakes in PL. Parkside Financial Bank & Trust lifted its holdings in Planet Labs PBC by 92.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,550 shares of the company’s stock worth $31,000 after purchasing an additional 745 shares in the last quarter. MCF Advisors LLC purchased a new stake in Planet Labs PBC during the 3rd quarter worth about $32,000. Baillie Gifford & Co. purchased a new stake in Planet Labs PBC during the 4th quarter worth about $32,000. Larson Financial Group LLC purchased a new stake in Planet Labs PBC during the 3rd quarter worth about $39,000. Finally, GAMMA Investing LLC lifted its holdings in Planet Labs PBC by 146.4% during the 4th quarter. GAMMA Investing LLC now owns 2,011 shares of the company’s stock worth $40,000 after purchasing an additional 1,195 shares in the last quarter. Hedge funds and other institutional investors own 41.71% of the company’s stock.

About Planet Labs PBC

(Get Free Report)

Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.

Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.

See Also

Receive News & Ratings for Planet Labs PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Planet Labs PBC and related companies with MarketBeat.com's FREE daily email newsletter.